Inogen | INGN - Market Capitalization


Inogen reported $122.2M in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 158.05B 20.36B Jun/2026
AngioDynamics USD 511M 94M Sep/2025
Artivion USD 2.18B 176M Dec/2025
AtriCure USD 1.42B 28M Jun/2026
Baxter International USD 11.01B 2.34B Jun/2026
Becton, Dickinson and Co. USD 41.7B 3.07B Jun/2026
Boston Scientific USD 63.44B 29.82B Jun/2026
Cooper Companies USD 12.67B 1.44B Sep/2026
Dexcom USD 25.99B 1.82B Jun/2026
Edwards Lifesciences USD 52.09B 5.92B Jun/2026
Globus Medical USD 10.73B 963M Jun/2026
Insulet USD 10.55B 3.99B Jun/2026
Medtronic USD 113.81B 4.51B Sep/2026
Orthofix International USD 604M 25M Dec/2025
Philips EUR 23.09B 615.44M Jun/2026
ResMed USD 28.27B 4.43B Jun/2026
Steris USD 20.52B 1.16B Jun/2026
Stryker USD 120.7B 5.15B Jun/2026
Tandem Diabetes Care USD 1.03B 276M Jun/2026
Teleflex USD 5.61B 317M Jun/2026
X T L Biopharmaceuticals USD 22M 8M Dec/2024
Zimmer Biomet Holdings USD 16.66B 845M Jun/2026